Pomerantz LLP

law_firm

Last mentioned: 4d ago

Timeline

  1. Pomerantz announces class actions

    Pomerantz issued press releases notifying investors of filed lawsuits and upcoming lead plaintiff deadlines.

  2. Pomerantz LLP Announces Investigations

    Pomerantz issues press releases for all five companies, seeking lead plaintiffs for potential securities class actions.

  3. Celsius Texas AG Investigation

    Texas AG Paxton announces investigation into Celsius's marketing of high-caffeine drinks to children. Stock falls 7.53%.

  4. Compass Antitrust Probe Disclosure

    Media reports NY AG antitrust investigation into Compass's $1.6B acquisition of Anywhere Real Estate. Stock falls 11.82%.

  5. Wise Money Laundering Report

    The Bureau of Investigative Journalism reports Belgian probe into Wise accounts used for money laundering. Stock falls 4.63% on June 2.

  6. Photronics Q2 Earnings Miss

    Photronics reports Q2 revenue of $209M, down YoY, and operating margin contraction. Stock falls 36.4%.

  7. Gap Inc. Q1 Earnings Miss

    Gap reports Q1 revenue of $3.5B, 1% growth YoY, missing estimates; cuts full-year guidance. Stock falls 15.4% on May 29.

  8. Verra Mobility contract termination disclosure

    Received Avis Budget Group termination notice effective Sep 2026; revised 2026 outlook downward; cost cuts planned. Stock crashed 70.57% to $3.85 on May 27.

  9. GeneDx Q1 2026 results

    Adjusted gross margin 74%→69%, FY revenue guide cut to $475–$490M from $540–$555M, and $31.3M impairment on Fabric Genomics. Stock drop implied.

  10. Badger Meter Q1 2026 results

    EPS of $0.93 missed by $0.26, revenue of $202.03M missed by $28.58M; utility water sales -10% YoY. Stock fell 24.13% to $115.54.

  11. PicS Q4/FY 2025 results

    Enhanced ECL calculation reclassified R$590M loans to Stage 3, causing R$88M ($17.56M) ECL increase. Stock fell 22.5% to $12.27.

  12. PicS N.V. initial public offering

    PicS sold approx. 22.9M shares at $19.00 per share on NASDAQ.

  13. Helen of Troy Q2 2026 results

    Quarterly sales down 8.9% YoY, adjusted EPS down 51%, with ongoing disruption warnings. Stock fell 25%.

  14. Helen of Troy Q1 2026 results

    Net sales down 11% YoY, adjusted EPS down nearly 60%, and $414.4M goodwill impairment. Stock fell nearly 23%.

  15. GeneDx announces acquisition of Fabric Genomics

    GeneDx agreed to acquire Fabric Genomics, an AI-driven genomic interpretation firm.

  16. Helen of Troy Q1 2025 results

    Reported 49% YoY decline in EPS and cut full-year revenue outlook by >20%. Stock fell nearly 28%.

Stories mentioning Pomerantz LLP 2

About Pomerantz LLP coverage

This page surfaces every story mentioning Pomerantz LLP across our legal coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.

Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running legal beat. Cross-entity comparisons live on our compare view.

What you seeWhat it tells you
Story countNumber of distinct stories where Pomerantz LLP was a primary or referenced actor.
Recency clusteringWhether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc).
Sentiment distributionAggregate sentiment of the stories mentioning this entity, weighted by impact score.
Cross-niche linksWhen the same entity surfaces in our sibling networks, we link to those views to enrich context.